COMP2COMP bmd
COMP2COMP bmd has been studied in 1 paper since 2026: none in people yet; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 10, 2026: “Comp2Comp: Open-Source Software with FDA-Cleared Artificial Intelligence Algorithms for Computed Tomography Image Analysis”.
1 paper studies it1 findingUpdated
See all 1 papers on COMP2COMP bmd
- In silico1
What is COMP2COMP bmd linked with?
1Studies link COMP2COMP bmd with 1 measure, most often Low bone density detection accuracy (1 study).
Low bone density detection accuracy
upin silico1
1 study
Low bone density detection accuracy
upin silico1
COMP2COMP bmd predicts low bone density detection accuracy in silico (sensitivity 81.0% (95% CI 74.0-86.8%), specificity 78.4% (95% CI 72.3-83.7%)).
“BMD had a sensitivity of 81.0% (95% CI 74.0-86.8%) and specificity of 78.4% (95% CI 72.3-83.7%).”
In silicon = 371
arXivPreprint
Latest
1 paper in 12 monthsarXiv
Comp2Comp: Open-Source Software with FDA-Cleared Artificial Intelligence Algorithms for Computed Tomography Image Analysis
Preprint: computational studyAI & data